User:Daniel Schemenauer/Sandbox 1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 18: Line 18:
===Interactions with a Negative Allosteric Modulator===
===Interactions with a Negative Allosteric Modulator===
The structure of mGlu<sub>5</sub> bound to the NAM [https://en.wikipedia.org/wiki/Mavoglurant Mavoglurant] demonstrates how protein activity is decreased through drug interactions.   
The structure of mGlu<sub>5</sub> bound to the NAM [https://en.wikipedia.org/wiki/Mavoglurant Mavoglurant] demonstrates how protein activity is decreased through drug interactions.   
<scene name='72/726404/Scene_7/2'>Mavoglurant</scene> binds within the core of the seven trans-membrane α-helices, forming multiple interactions with the protein that further stabilize the inactive conformation.  
<scene name='72/726404/Scene_7/2'>Mavoglurant</scene> binds within the allosteric binding site in the core of the seven trans-membrane α-helices,having passed through the restricted entrance formed by the ECL2.  Bound Mavoglurant forms multiple interactions with the protein that further stabilize the inactive conformation.  
The bicyclic ring system of the drug is surrounded by a pocket of mainly hydrophobic residues including Val 806, Met 802, Phe 788, Trp 785, Leu 744, Ile 651, Pro 655 and Asn 747<ref name="Primary">PMID: 25042998 </ref> (Figure 1). The carbamate tail of mavoglurant forms a hydrogen bond through its carbonyl oxygen to the amide side-chain of Asparagine 747 of TM4 (Figure 2). A hydroxyl group similarly forms hydrogen bonds to the protein, specifically to two serine residues (S805 and S809) of TM7 which form a hydrogen bonding network to other residues through their main chain atoms and a coordinated water molecule (omitted for clarity) (Figure 3). The interactions between Mavoglurant andmGlu<sub>5</sub> involved TM helices that were not previously stabilized by any strong interactions, introducing a new level of stability that favors the inactive conformation of the protein and hence decrease activity<ref name="Primary">PMID: 25042998 </ref>.
The bicyclic ring system of the drug is surrounded by a pocket of mainly hydrophobic residues including Val 806, Met 802, Phe 788, Trp 785, Leu 744, Ile 651, Pro 655 and Asn 747<ref name="Primary">PMID: 25042998 </ref> (Figure 1). The carbamate tail of mavoglurant forms a hydrogen bond through its carbonyl oxygen to the amide side-chain of Asparagine 747 of TM4 (Figure 2). A hydroxyl group similarly forms hydrogen bonds to the protein, specifically to two serine residues (S805 and S809) of TM7 which form a hydrogen bonding network to other residues through their main chain atoms and a coordinated water molecule (omitted for clarity) (Figure 3). The interactions between Mavoglurant andmGlu<sub>5</sub> involved TM helices that were not previously stabilized by any strong interactions, introducing a new level of stability that favors the inactive conformation of the protein and hence decrease activity<ref name="Primary">PMID: 25042998 </ref>.
[[Image:Mav_Hydrophobic_pocket.png |500 px|left|thumb|Figure 1.Hydrophobic Pocket Surrounding Mavoglurant]]
[[Image:Mav_Hydrophobic_pocket.png |500 px|left|thumb|Figure 1.Hydrophobic Pocket Surrounding Mavoglurant]]